Actively Recruiting
Evaluation of Chemotherapy Induced Neuropathy in Solid Cancer Patients
Led by Swami Rama Himalayan University · Updated on 2024-07-08
124
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this prospective study is to perform Nerve conduction test, Vitamin D, Vitamin B12 and NADPH oxidase 4(NOX4) expression to assess severity of chemotherapy induced Peripheral neuropathy (CIPN) in solid cancer (Head and Neck, Breast, Prostate) patients who planned for at least 4 cycle of chemotherapy in different nutrient status level and gene expression.
CONDITIONS
Brief Title
Chemotherapy Induced Neuropathy in Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients receiving chemotherapy for solid cancer
- Patient aged>18years
You will not qualify if you...
- Age ≤ 18 years
- Pre-existing neuropathy
- Patients diagnosed with Psychiatric illness
- Patients with pre-existing peripheral neuropathy
- Patients taking medication for neuropathy
- Long standing diabetes (>10 years)
- Renal and Hepatic disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences
Dehradun, India, 248016
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here